|
|  |
 Printer Friendly
 Text Version  Email Page
| Updated Hib Interim Schedule (10/27/08)
Agency:
Community Health
|
CDC has provided the following guidance on the use of Hib vaccine during the shortage, as well as FAQ handouts for both parents and providers.
Background
On 12/13/07, Merck and Co., Inc. announced a voluntary recall of
certain lots of two Haemophilus influenzae type b (Hib) conjugate vaccines
, PedvaxHIB and Comvax (Hib/Hep B) and suspended production of its Hib conjugate vaccines. Stocking vaccine to give the booster dose during the shortage can take away from providers who are struggling to provide the primary series. Until adequate supplies of Hib vaccine are available, providers should use the interim Hib recommendations and schedule. Plans should be put into place to recall children who need the booster dose after the shortage is resolved.
|
|
|
|
